These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36693765)

  • 21. The short-time effect of latanoprost on the intraocular pressure in normal pressure glaucoma.
    Kjellgren D; Douglas G; Mikelberg FS; Drance SM; Alm A
    Acta Ophthalmol Scand; 1995 Jun; 73(3):233-6. PubMed ID: 7493234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of latanoprost or 8-iso prostaglandin E2 alone and in combination on intraocular pressure in glaucomatous monkey eyes.
    Wang RF; Podos SM; Serle JB; Mittag TW; Ventosa F; Becker B
    Arch Ophthalmol; 2000 Jan; 118(1):74-7. PubMed ID: 10636418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
    Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma.
    Aspberg J; Heijl A; Jóhannesson G; Lindén C; Andersson-Geimer S; Bengtsson B
    J Glaucoma; 2018 Nov; 27(11):976-980. PubMed ID: 30113517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, 36-month, post-marketing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension.
    Friström B; Uusitalo H
    Acta Ophthalmol; 2010 Feb; 88(1):37-43. PubMed ID: 19900212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of latanoprost for glaucoma treatment: a three-month multicentric study in India.
    Thomas R; Parikh R; Sood D; Vijaya L; Sekhar GC; Sood NN; Baskaran M; Prasad KK;
    Indian J Ophthalmol; 2005 Mar; 53(1):23-30. PubMed ID: 15829743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Dec; 4(4):283-8. PubMed ID: 11906665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma.
    Xu J; Ge Y; Bu R; Zhang A; Feng S; Wang J; Gou J; Yin T; He H; Zhang Y; Tang X
    J Control Release; 2019 Jul; 305():18-28. PubMed ID: 31103677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication.
    Magacho L; Reis R; Shetty RK; Santos LC; Avila MP
    Ophthalmology; 2006 Mar; 113(3):442-5. PubMed ID: 16458964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study.
    Shoji N; Ogata H; Suyama H; Ishikawa H; Suzuki H; Morita T; Kawai H; Nishimoto H; Nemoto T; Shimizu K
    Curr Med Res Opin; 2005 Apr; 21(4):503-8. PubMed ID: 15899098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of latanoprost in eyes with uveitic glaucoma.
    Markomichelakis NN; Kostakou A; Halkiadakis I; Chalkidou S; Papakonstantinou D; Georgopoulos G
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):775-80. PubMed ID: 19184081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
    Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
    Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.
    Payet S; Denis P; Berdeaux G; Launois R
    Clin Drug Investig; 2008; 28(3):183-98. PubMed ID: 18266403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
    Oddone F; Kirwan J; Lopez-Lopez F; Zimina M; Fassari C; Holló G;
    Adv Ther; 2022 Aug; 39(8):3501-3521. PubMed ID: 35524840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma.
    Rulo AH; Greve EL; Geijssen HC; Hoyng PF
    Ophthalmology; 1996 Aug; 103(8):1276-82. PubMed ID: 8764799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
    Simmons ST; Earl ML;
    Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
    Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.